1. Immunogenicity and Clinical Efficacy Combined Vaccine against Diphtheria, Tetanus and Hepatitis B in Patients with Chronic Obstructive Pulmonary Disease
- Author
-
M. P. Kostinov, N. A. Kulakova, O. O. Magarshak, V. N. Borisova, V. B. Polishchuk, A. M. Kostinova, A. A. Ryzhov, and A. M. Kostinov
- Subjects
хобл ,комплексная вакцина ,поствакцинальные антитела ,дифтерия ,столбняк ,гепатит в ,copd ,associated vaccine ,post-vaccination antibodies ,diphtheria ,tetanus ,hepatitis b ,Epistemology. Theory of knowledge ,BD143-237 - Abstract
The article presents the results of vaccination against diphtheria, tetanus and hepatitis B virus with the use of combined vaccine Bubo-M or a monovalent vaccine Hepatitis B in 120 patients with severe and medium chronic obstructive pulmonary disease (COPD) and 77 healthy people at the age 35 - 60 years. The lack of protective antibodies to diphtheria in patients with COPD was noted. The safety of immunization and the delayed production of post-vaccination antibodies to these infections were shown. The level of post-vaccination antibodies was the same as in healthy group after the administration of 3-rd dose both of the monovaccine and the combined one. During the year a clinical effect in reducing the number of exacerbations of the disease after a triple injection of the combined Bubo-M vaccine in patients with COPD was observed, comparable to that in patients with the combined use of the immunomodulator and hepatitis B vaccine. Moreover combined vaccination with immunomodulator led to normalization of level of the inflammatory mediators. Conclusion: Vaccination of patients with COPD with the use of the combined vaccine Bubo-M has both an advantages in clinical effect and the spectrum of anti-infection protection in comparison with the monovaccine against hepatitis
- Published
- 2017
- Full Text
- View/download PDF